Status:
UNKNOWN
Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy
Lead Sponsor:
Rabin Medical Center
Conditions:
Prostate Biopsy
Eligibility:
MALE
18-90 years
Phase:
NA
Brief Summary
This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy
Detailed Description
This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy among men. The target population are males that are schedule to undergo MRI-US Fusion p...
Eligibility Criteria
Inclusion
- Men who are scheduled to undergo, transrectal or transperineal biopsy and have an MRI of the prostate.
- • Either primary biopsy or repeated biopsy
- Age 18-90.
- PI-RADS classification of 3-5
Exclusion
- Men who do not have an MRI of the prostate.
- PI-RADS classification of 2 or lower
- Men who were diagnosed with prostate cancer and have begun treatment
Key Trial Info
Start Date :
December 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT03413137
Start Date
December 11 2017
End Date
October 1 2019
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center, Beilinson campus
Petah Tikva, Israel, 4941492